STOCK TITAN
  1. Home
  2. News
  3. PHR

Phreesia, Inc. - $PHR STOCK NEWS

Welcome to our dedicated page for Phreesia news (Ticker: $PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Phreesia's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Phreesia's position in the market.

News
Phreesia’s Alicia Cowley and Natasha Vega Named to MM+M’s ‘Women to Watch’ for 2024
Rhea-AI Summary

Phreesia's Alicia Cowley and Natasha Vega have been named to MM+M's 'Women to Watch' for 2024, highlighting their significant impact on the healthcare marketing industry. Cowley, as Director of Clinical Content, and Vega, as Senior Client Experience Manager, were recognized for their leadership and contributions to Phreesia's vision of empowering patients in their healthcare journey.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
none
-
News
Phreesia Sets Release Date for Fiscal First Quarter 2025 Results
Rhea-AI Summary

Phreesia, Inc. (NYSE: PHR) has announced the release date for its fiscal first quarter 2025 financial results, set for after market trading on Thursday, May 30, 2024. The company will issue a press release and a quarterly stakeholder letter, to be posted on their investor website at ir.phreesia.com. A conference call to discuss the results will take place at 5PM Eastern Time on the same day. Phreesia is a leader in patient activation, enabling approximately 150 million patient visits in 2023 and offering digital solutions to enhance the patient experience and improve healthcare outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
earnings
-
News
Phreesia Announces Jack Callahan as New Chief Technology Officer
Rhea-AI Summary
Phreesia appoints Jack Callahan as Chief Technology Officer, succeeding Dan Nathan. Callahan, with 14 years at Phreesia, aims to enhance the platform to address healthcare challenges. Nathan remains as Senior Engineering Advisor. CEO Chaim Indig lauds Nathan's contributions and trusts Callahan's leadership for future product innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
News
Phreesia Announces Fourth Quarter Fiscal 2024 Results
Rhea-AI Summary
Phreesia, Inc. (PHR) reports strong financial results for Q4 and FY 2024, with revenue up 27% year-over-year. Despite a net loss, the company shows growth in AHSCs and total revenue. The outlook for FY 2025 indicates continued growth and improved Adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
earnings
-
News
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
Rhea-AI Summary
Phreesia's Chief Clinical Officer, Dr. Hilary Hatch, selected for NQF's 2024-2025 Leadership Consortium, showcasing dedication to healthcare quality and patient-centered care. Dr. Hatch leads clinical programs, research partnerships, and patient engagement efforts at Phreesia, emphasizing the importance of patient activation in improving health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
-
News
New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates
Rhea-AI Summary
Phreesia's breast cancer-prevention campaign resulted in 32% of patients requesting a screening, showcasing the positive impact of their platform on increasing cancer screening rates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.32%
Tags
none
News
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
Rhea-AI Summary
Phreesia, Inc. (PHR) will release its fiscal fourth quarter 2024 financial results on March 14, 2024, followed by a conference call to discuss the results. The company's quarterly stakeholder letter and press release will be available on its investor website. Participants can join the conference call via phone or webcast, with a replay available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
earnings
-
News
Phreesia Joins Call to Action to Improve Adult Vaccination Rates
Rhea-AI Summary
Phreesia has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates. The campaign aims to encourage healthcare providers to take action to protect adults from preventable illness, disability, and death. More than three in four adults are missing routinely recommended vaccines, and low vaccination rates have worsened due to preventive care put on hold during the COVID-19 pandemic. Phreesia's vaccine management tools support healthcare organizations by collecting critical information, engaging patients, and giving them the resources they need to make informed decisions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
-
News
Phreesia’s Audrey Gato Named as a Top Woman Leader in SaaS
Rhea-AI Summary
Phreesia's Vice President of Client Solutions, Audrey Gato, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2023, marking the sixth consecutive year a female leader from Phreesia has been recognized. Gato's role involves overseeing client implementation and account management for Phreesia’s payer and managed service offerings, as well as leading client efforts around clinical programs such as the Kidney Care Choices (KCC) Model and Merit-based Incentive Payment System (MIPS). The Software Report highlighted the diverse leadership roles of the award recipients, emphasizing their adept leadership within the SaaS industry. Gato expressed her honor in being recognized and emphasized Phreesia's commitment to introducing new initiatives and products to serve clients and the healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
News
Phreesia’s Post-Script Engagement named one of PM360’s 2023 Most Innovative Technologies
Rhea-AI Summary
Phreesia (PHR) has been recognized by PM360 for its innovative medication adherence solution, Post-Script Engagement, being named to the list of 2023 Most Innovative Marketing Technologies or Services. The offering was selected as one of 56 overall honorees, and one of just 8 technologies or services to be recognized for marketing innovation. Post-Script Engagement provides patients with resources to adhere to their medication as soon as their prescription is written, delivering curated content in a secure manner. The engagement also includes a survey to measure patients' likelihood to fill their prescription, providing insights to help doctors tailor their interactions with patients to address their unique adherence challenges. Phreesia's VP of Product Management, Kristin Roberts, expressed pride in offering Post-Script Engagement as part of a medication adherence product suite that supports patients, providers, and life sciences partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
none
Stock PHR logo
Phreesia, Inc.

NYSE:PHR

PHR Rankings

#2271 Ranked by Market Cap
#4785 Ranked by Stock Gains
N/A Ranked by Dividends

PHR Stock Data

1.27B
53.49M
4.78%
94.64%
3.84%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States of America
WILMINGTON

About PHR

leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.